Gratsianskii N A, Vaulin N A
Laboratory of Clinical Cardiology, Institute of Physicochemical Medicine, Federal Agency on Health Care and Social Development, Moscow.
Bull Exp Biol Med. 2007 Sep;144(3):438-46. doi: 10.1007/s10517-007-0348-8.
We present the results of the study of lipid-modulating drugs (pravastatin, atorvastatin, simvastatin, and fibrate gemfibrozil) in complicated coronary heart disease (acute coronary syndrome without ST elevation, chronic heart failure. In acute coronary syndrome statins produced a positive effect on some studied parameters, while in heart failure only the safety of short-term therapy with statins was demonstrated.
我们展示了脂质调节药物（普伐他汀、阿托伐他汀、辛伐他汀和贝特类药物吉非贝齐）在复杂性冠心病（非ST段抬高型急性冠脉综合征、慢性心力衰竭）中的研究结果。在急性冠脉综合征中，他汀类药物对一些研究参数产生了积极影响，而在心力衰竭中，仅证明了他汀类药物短期治疗的安全性。
